Theriva Biologics, Inc.TOVXNYSE
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank7
3Y CAGR-78.6%
5Y CAGR-61.4%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
-78.6%/yr
Annual compound
5Y CAGR
-61.4%/yr
Recent deceleration
Percentile
P7
Near historical low
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.12 | -29.1% |
| 2023 | 0.17 | +36.5% |
| 2022 | 0.13 | -99.0% |
| 2021 | 12.68 | -44.1% |
| 2020 | 22.67 | +56.3% |
| 2019 | 14.50 | +388.0% |
| 2018 | 2.97 | +100.3% |
| 2017 | -1089.81 | -333.3% |
| 2016 | 467.05 | +62.4% |
| 2015 | 287.57 | - |